Ascend acquires Beacon Gene Therapy manufacturing site

Ascend Gene and Cell Therapies Ltd, the UK based specialist CDMO (Contract Development & Manufacturing Organization) that creates manufacturing processes for gene therapy technologies, has acquired the Chemistry, Manufacturing and Controls (CMC) team and site in Alachua, Florida from Beacon Therapeutics Ltd, the UK and US based ophthalmic gene therapy company.
Click here to read the press release
Subscribe to our Newsletter

CapMan Buyout exits Havator to BMS Stangeland

April 24, 2024

BMS Stangeland AS, the Denmark based joint venture owned by the Danish–Norwegian crane operator BMS Group AS and Stangeland Gruppen …

Read More →

Apollo Global Management to acquire a minority stake in Autodoc SE

April 24, 2024

Apollo Global Management LLC, the US based global alternative investment management firm, through its funds associated with the Hybrid Value …

Read More →

GRO Capital AS acquires DigitalRoute

April 23, 2024

Gro Capital AS (fka DKA Capital AS), the Denmark based private equity firm, has acquired Digital Route AB, the Sweden …

Read More →

Hasko becomes new majority owner in Sport Design Sweden AB

April 23, 2024

Hasko Invest AB, the Sweden based investment company, has acquired a majority stake in Sport Design Sweden AB, the Sweden …

Read More →

KKR to acquire Immedica Pharma

April 23, 2024

Kohlberg Kravis Roberts & Co (KKR), the US based global private equity firm, via its KKR Health Care Strategic Growth …

Read More →

IK Investment Partners acquires a minority stake in A-SAFE

April 23, 2024

IK Investment Partners Limited, the UK based private equity firm, has acquired a minority stake in A-SAFE, the UK based …

Read More →
Load More
close-link
close-link